165 related articles for article (PubMed ID: 29112991)
1. Immuno-virological response and associated factors amongst HIV-1 vertically infected adolescents in Yaoundé-Cameroon.
Fokam J; Billong SC; Jogue F; Moyo Tetang Ndiang S; Nga Motaze AC; Paul KN; Njom Nlend AE
PLoS One; 2017; 12(11):e0187566. PubMed ID: 29112991
[TBL] [Abstract][Full Text] [Related]
2. Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: adolescents at high risk of virological failure in the era of "test and treat".
Fokam J; Sosso SM; Yagai B; Billong SC; Djubgang Mbadie RE; Kamgaing Simo R; Edimo SV; Nka AD; Tiga Ayissi A; Yimga JF; Takou D; Moudourou S; Ngo Nemb M; Nfetam Elat JB; Santoro MM; Perno CF; Colizzi V; Ndjolo A
AIDS Res Ther; 2019 Nov; 16(1):36. PubMed ID: 31744517
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of protease inhibitor-based antiretroviral therapy amongst children and associated-factors in Yaoundé, Cameroon.
Njom Nlend AE; Guessong CO; Nga Motaze AC; Soffo C; Koki Ndombo PO; Tsambang L; Fokam J
PLoS One; 2019; 14(3):e0213900. PubMed ID: 30883591
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional study.
Zoufaly A; Fillekes Q; Hammerl R; Nassimi N; Jochum J; Drexler JF; Awasom CN; Sunjoh F; Burchard GD; Burger DM; van Lunzen J; Feldt T
Antivir Ther; 2013; 18(5):681-90. PubMed ID: 23502762
[TBL] [Abstract][Full Text] [Related]
5. Determinants of switch to paediatric second-line antiretroviral therapy after first-line failure in Cameroon.
Njom-Nlend AE; Efouba N; Brunelle Sandie A; Fokam J
Trop Med Int Health; 2021 Aug; 26(8):927-935. PubMed ID: 33905593
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory profile of vertically HIV-1 infected adolescents receiving ART in Cameroon: a contribution toward optimal pediatric HIV control strategies.
Ka'e AC; Nanfack AJ; Ambada G; Santoro MM; Takou D; Semengue ENJ; Nka AD; Bala MLM; Endougou ON; Elong E; Beloumou G; Djupsa S; Gouissi DH; Fainguem N; Tchouaket MCT; Sosso SM; Kesseng D; Ndongo FA; Sonela N; Kamta ACL; Tchidjou HK; Ndomgue T; Ndiang STM; Nlend AEN; Nkenfou CN; Montesano C; Halle-Ekane GE; Cappelli G; Tiemessen CT; Colizzi V; Ceccherini-Silberstein F; Perno CF; Fokam J
Front Immunol; 2023; 14():1239877. PubMed ID: 37646023
[TBL] [Abstract][Full Text] [Related]
7. Characterization of oral candidiasis according to antiretroviral treatment status, immunological and virological profiles among HIV infected patients in two health facilities in Yaoundé-Cameroon: a cross-sectional and analytical study.
Fokam J; Nka AD; Semengue ENJ; Asso'o CKE; Gabisa JE; Ka'e AC; Bouba Y; Pabo W; Geh BKN; Gouissi D; Chenwi CA; Tchouaket MCT; Abba A; Takou D; Fainguem N; Kamgaing RS; Sosso SM; Abena MEN; Ndjolo A
Pan Afr Med J; 2023; 45():33. PubMed ID: 37545607
[TBL] [Abstract][Full Text] [Related]
8. Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics.
Fokam J; Nka AD; Mamgue Dzukam FY; Efakika Gabisa J; Bouba Y; Tommo Tchouaket MC; Ka'e AC; Ngoufack Jagni Semengue E; Takou D; Moudourou S; Fainguem N; Pabo W; Nayang Mundo RA; Kengni Ngueko AM; Ambe Chenwi C; Flore Yimga J; Nnomo Zam MK; Simo Kamgaing R; Tangimpundu C; Kamgaing N; Njom-Nlend AE; Ndombo Koki P; Kesseng D; Ndiang Tetang S; Kembou E; Ebiama Lifanda L; Pamen B; Ketchaji A; Saounde Temgoua E; Billong SC; Zoung-Kanyi Bissek AC; Hadja H; Halle EG; Colizzi V; Perno CF; Sosso SM; Ndjolo A
Medicine (Baltimore); 2023 May; 102(20):e33737. PubMed ID: 37335723
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of treatment response, drug resistance and HIV-1 variability among adolescents on first- and second-line antiretroviral therapy: a study protocol for a prospective observational study in the centre region of Cameroon (EDCTP READY-study).
Fokam J; Santoro MM; Takou D; Njom-Nlend AE; Ndombo PK; Kamgaing N; Kamta C; Essiane A; Sosso SM; Ndjolo A; Colizzi V; Perno CF
BMC Pediatr; 2019 Jul; 19(1):226. PubMed ID: 31277610
[TBL] [Abstract][Full Text] [Related]
10. Viral load suppression in HIV-infected adolescents in cameroon: towards achieving the UNAIDS 95% viral suppression target.
Djiyou ABD; Penda CI; Madec Y; Ngondi GD; Moukoko A; Varloteaux M; de Monteynard LA; Moins C; Moukoko CEE; Aghokeng AF
BMC Pediatr; 2023 Mar; 23(1):119. PubMed ID: 36922769
[TBL] [Abstract][Full Text] [Related]
11. Association between mental disorders with detectable viral load and poor adherence to antiretroviral therapy among adolescents infected with Human Immunodeficiency Virus on follow-up at Chantal Biya Foundation, Cameroon.
Ndongo FA; Kana R; Nono MT; Noah JYA; Ndzie P; Tejiokem MC; Biheng EH; Ndie J; Nkoa TA; Ketchaji A; Ngako JN; Penda CI; Bissek ACZ; Ndombo POK; Hawa HM; Msellati P; Lallemant M; Faye A
J Epidemiol Popul Health; 2024 Apr; 72(2):202193. PubMed ID: 38523399
[TBL] [Abstract][Full Text] [Related]
12. Correlation between the immuno-virological response and the nutritional profile of treatment-experienced HIV-infected patients in the East region of Cameroon.
Abba A; Fokam J; Kamgaing RS; Yimga JF; Ka'e AC; Nka AD; Tchouaket MCT; Chenwi CA; Semengue ENJ; Ndjolo A; Sosso SM
PLoS One; 2021; 16(5):e0229550. PubMed ID: 33983976
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort study.
Togna Pabo WLR; Fokam J; Njume D; Takou D; Santoro MM; Nyasa RB; Chenwi C; Mpouel ML; Beloumou G; Jagni ESN; Nka AD; Ka'e AC; Teto G; Dambaya B; Djupsa S; Gouissi Anguechia DH; Evariste M; Kamta C; Bala L; Lambo V; Halle-Ekane EG; Colizzi V; Perno CF; Ndjolo A; Ndip Ndip R
PLoS One; 2023; 18(10):e0293326. PubMed ID: 37878637
[TBL] [Abstract][Full Text] [Related]
14. Long-term immune and virological response in HIV-infected patients receiving antiretroviral therapy.
Silveira MP; Silveira CP; Guttier MC; Page K; Moreira LB
J Clin Pharm Ther; 2016 Dec; 41(6):689-694. PubMed ID: 27676134
[TBL] [Abstract][Full Text] [Related]
15. Improved virological suppression in children on antiretroviral treatment receiving community-based adherence support: a multicentre cohort study from South Africa.
Fatti G; Shaikh N; Eley B; Grimwood A
AIDS Care; 2014 Apr; 26(4):448-53. PubMed ID: 24215157
[TBL] [Abstract][Full Text] [Related]
16. Alarming rates of virological failure and HIV-1 drug resistance amongst adolescents living with perinatal HIV in both urban and rural settings: evidence from the EDCTP READY-study in Cameroon.
Fokam J; Takou D; Njume D; Pabo W; Santoro MM; Njom Nlend AE; Beloumou G; Sosso S; Moudourou S; Teto G; Dambaya B; Djupsa S; Tetang Ndiang S; Ateba FN; Billong SC; Kamta C; Bala L; Lambo V; Tala V; Chenwi Ambe C; Mpouel ML; Cappelli G; Cham F; Ndip R; Mbuagbaw L; Koki Ndombo P; Ceccherini-Silberstein F; Colizzi V; Perno CF; Ndjolo A
HIV Med; 2021 Aug; 22(7):567-580. PubMed ID: 33792134
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of WHO immunological criteria in identifying virological failure among HIV-infected adults on First line antiretroviral therapy in Mwanza, North-western Tanzania.
Gunda DW; Kidenya BR; Mshana SE; Kilonzo SB; Mpondo BC
BMC Res Notes; 2017 Jan; 10(1):45. PubMed ID: 28095920
[TBL] [Abstract][Full Text] [Related]
18. Virological outcomes of antiretroviral therapy in Zomba central prison, Malawi; a cross-sectional study.
Mpawa H; Kwekwesa A; Amberbir A; Garone D; Divala OH; Kawalazira G; van Schoor V; Ndindi H; van Oosterhout JJ
J Int AIDS Soc; 2017 Aug; 20(1):21623. PubMed ID: 28782332
[TBL] [Abstract][Full Text] [Related]
19. Virological failure after 1 year of first-line ART is not associated with HIV minority drug resistance in rural Cameroon .
Zoufaly A; Jochum J; Hammerl R; Nassimi N; Raymond Y; Burchard GD; Schmiedel S; Drexler JF; Campbell NK; Taka N; Awasom C; Metzner KJ; van Lunzen J; Feldt T
J Antimicrob Chemother; 2015 Mar; 70(3):922-5. PubMed ID: 25428920
[TBL] [Abstract][Full Text] [Related]
20. Optimal antiretroviral therapy adherence as evaluated by CASE index score tool is associated with virological suppression in HIV-infected adults in Dakar, Senegal.
Byabene AK; Fortes-Déguénonvo L; Niang K; Manga MN; Bulabula ANH; Nachega JB; Seydi M
Trop Med Int Health; 2017 Jun; 22(6):776-782. PubMed ID: 28407436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
